Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

16 April 2026

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

73230 result(s) found, displaying 25826 to 25850

ABACAVIR/LAMIVUDINE GENERICHEALTH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ABACAVIR/LAMIVUDINE GENERICHEALTH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ABACAVIR/LAMIVUDINE GH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ABACAVIR/LAMIVUDINE GH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ADALAT OROS 60 nifedipine 60mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Bayer Australia Ltd
ADALAT OROS nifedipine 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Bayer Australia Ltd
AMISOLAN 50 amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMISULPRIDE AJS amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMISULPRIDE CH amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMLODIPINE CH amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMLODIPINE CH amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMLODIPINE GENERICHEALTH amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMLODIPINE GENERICHEALTH amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMLODIPINE SG amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMLODIPINE SG amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
AMOXYCILLIN/CLAVULANIC ACID-SPIRIT 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium) 125mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
AMOXYCILLIN/CLAVULANIC ACID-SPIRIT 875/125 amoxicillin (as trihydrate) 875mg and clavulanic acid (as potassium) 125mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
An Chuang Ling a.k.a. Salvia & Scute Acne Formula Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Sun Herbal Pty Ltd
ANAGRELIDE MGH anagrelide (as hydrochloride monohydrate) 0.5 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ANASTROZOLE GENERICHEALTH anastrozole 1 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Generic Health Pty Ltd
ANASTROZOLE MGH anastrozole 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
APOTEX-CEPHALEXIN cefalexin (as monohydrate) 250 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
APOTEX-CEPHALEXIN cefalexin (as monohydrate) 500 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ARO Investments Pty Ltd - Antisnoring mucosa lubricant Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by ARO Investments Pty Ltd
ARO Investments Pty Ltd - Nail treatment solution Cancelled under Section 41GL(d) of the Act

24 June 2022

Cancellation by sponsor

Requested by ARO Investments Pty Ltd

Last updated

16 April 2026

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

ABACAVIR/LAMIVUDINE GENERICHEALTH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

ABACAVIR/LAMIVUDINE GENERICHEALTH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack Cancelled under Section 30(1)(c) of the Act

ABACAVIR/LAMIVUDINE GH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

ABACAVIR/LAMIVUDINE GH 600/300 abacavir (as hydrochloride) 600 mg and lamivudine 300 mg film-coated tablet bottle pack Cancelled under Section 30(1)(c) of the Act

ADALAT OROS 60 nifedipine 60mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

ADALAT OROS nifedipine 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMISOLAN 50 amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMISULPRIDE AJS amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMISULPRIDE CH amisulpride 50 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE CH amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE CH amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE GENERICHEALTH amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE GENERICHEALTH amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE SG amlodipine 10 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMLODIPINE SG amlodipine 5 mg (as besilate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMOXYCILLIN/CLAVULANIC ACID-SPIRIT 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium) 125mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMOXYCILLIN/CLAVULANIC ACID-SPIRIT 875/125 amoxicillin (as trihydrate) 875mg and clavulanic acid (as potassium) 125mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

An Chuang Ling a.k.a. Salvia & Scute Acne Formula Cancelled under Section 30(1)(c) of the Act

ANAGRELIDE MGH anagrelide (as hydrochloride monohydrate) 0.5 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

ANASTROZOLE GENERICHEALTH anastrozole 1 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ANASTROZOLE MGH anastrozole 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APOTEX-CEPHALEXIN cefalexin (as monohydrate) 250 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

APOTEX-CEPHALEXIN cefalexin (as monohydrate) 500 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

ARO Investments Pty Ltd - Antisnoring mucosa lubricant Cancelled under Section 41GL(d) of the Act

ARO Investments Pty Ltd - Nail treatment solution Cancelled under Section 41GL(d) of the Act

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect